R63L (p.Arg63Leu) variant of MYBPC3 (Myosin-binding protein C, cardiac-type)
R63L (p.Arg63Leu) in MYBPC3 (Myosin-binding protein C, cardiac-type) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.28 / 1. The record also includes structural context.
R63L (p.Arg63Leu) variant details
- p.Arg63Leu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.282
- REVEL 0.31
- ESM-1b 0.00
- AlphaMissense 0.36
- SIFT 0.00
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available